The invention belongs to the technical field of biological
medicine, and discloses preparation of a Zr-based
heterojunction sound-sensitive agent and application of the Zr-based
heterojunction sound-sensitive agent in synergistic
tumor therapy, and the preparation process comprises the following steps: dissolving H2BDC and ZrOCl2. 8H2O in DMF, adding glacial
acetic acid, heating, centrifuging and washing to obtain Zr-MOF; the preparation method comprises the following steps: dissolving EDTA-FeNa
powder in deionized water, and carrying out ultrasonic mixing, annealing, centrifuging and filtering to obtain Fe-CDs; and finally, the Zr-MOF, the DOX and the Fe-CDs are mixed, and the DOX / Zr-MOF / Fe-CDs are prepared. The DOX / Zr-MOF / Fe-CDs nano platform is formed by combining Zr-MOF and Fe-
doped carbon dots (Fe-CDs), so that the DOX / Zr-MOF / Fe-CDs nano platform has excellent sonodynamic and chemical dynamic properties. The nano platform generates a large amount of
reactive oxygen species (ROS) under the action of
ultrasound,
glutathione (GSH) is indirectly consumed through a
Fenton reaction, and meanwhile Zr-MOF serves as a protective layer of degradation behaviors, so that DOX / Zr-MOF / Fe-CDs have controllable degradation behaviors. The invention solves the problems that the existing sonosensitizer ROS is low in yield and easy to consume by GSH, and is suitable for tumor treatment.